The Board of Directors and the Steering Committee of the Society of Hematologic Oncology are pleased to announce that Dr. Guillermo Garcia-Manero (GGM) assumed the position of SOHO President on September 10, 2023. He will oversee the society during the 2023-2024 term and will Chair the SOHO 2024 annual meeting scheduled for September 4-7, 2024.
GGM has served on the SOHO Steering, Education and Scientific committees since the inception of the society in 2012. His efforts have focused on improving the outcomes and quality of life of patients with leukemia and, in particular, myelodysplastic syndromes. His work centers around the understanding of the pathophysiology of these disorders in order to develop new therapeutic interventions. He currently leads the largest MDS program in the world and directs the MDS/AML Moon Shot® program at UT MD Anderson Cancer Center (MDACC). This work has resulted in over 500 publications in the areas of biology, therapy and prognostication of these disorders, and the development of multiple therapeutic clinical trials.
GGM is the Dr. Kenneth B. McCredie Chair in Clinical Leukemia Research in the Department of Leukemia at MDACC. He also serves as the Chief of the Section of Myelodysplastic Syndromes and Vice Chairman of the Department of Leukemia. In addition, GGM serves as the Program Director of the Leukemia Fellowship Program at MDACC.
GGM was born in Spain and received his medical degree and training at the University of Zaragoza in Spain and at the Royal Free Hospital in London, UK. He completed his internship and residency in Internal Medicine at Thomas Jefferson University Hospital in Philadelphia, PA and his fellowship in Hematology and Medical Oncology at the Cardeza Foundation for Hematology Research, Sidney Kimmel Cancer Center at Thomas Jefferson University Hospital, where he served as Chief Fellow. In 1999, he became Assistant Professor in the Department of Leukemia at MDACC where he continues to improve outcomes for patients diagnosed with MDS and leukemia.